American Heart Association. Heart disease and stroke statistics—2008 update. Dallas, Texas: American Heart Association; 2008.
Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419.
Dawes MG, Bartlett G, Coats AJ, Juszczak E. Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting. Ann Fam Med. 2008;6(5):390-396.
Health Care Financing Administration. Acute myocardial infarction national project overview. HCFA Pub. No. 10156. 2008. http://permanent.access.gpo.gov/websites/www.hcfa.gov/quality/download/3y.pdf. Accessed May 21, 2009.
The Joint Commission. Performance measurement initiatives. 2008. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement. Accessed May 21, 2009.
Labinson PT, Giacco S, Gift H, Mansoor GA, White WB. The importance of the clinical observer in the development of a white-coat effect in African-American patients with hypertension. Clin Meth Pathophysiol. 2008;13(3):139-142.
Leibovitch ER. Hypertension 2008, refining our treatment. Geriatrics. 2008;63(10):14-20.
National Heart Lung and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2003. www.nhlbi.nih.gov/guidelines/hypertension/. Accessed May 21, 2009.
Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States, 2005–2006. NCHS Data Brief No. 3. Hyattsville, MD: National Center for Health Statistics; 2008. www.cdc.gov/nchs/data/databriefs/db03.pdf. Accessed May 21, 2009.
Saseen JJ, Carter BL. Hypertension. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy. A Pathophysiologic Approach. Vol. 13. 6th ed. New York, NY: McGraw-Hill; 2005:185-217.
